Curis to Present at Upcoming Healthcare Conference in April
Press Releases
April 3, 2025

Curis to Present at Upcoming Healthcare Conference in April

LEXINGTON, Mass., April 2, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced

bradford

The Bradford Era

Local & Social